Sep 20, 2024 4:05pm EDT iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Aug 12, 2024 4:30pm EDT iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development
May 13, 2024 4:05pm EDT iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
Mar 27, 2024 7:00am EDT iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
